Nanotechnology Now - Press Release: Arrowhead to Present at Upcoming Investor Conferences

Home > Press > Arrowhead to Present at Upcoming Investor Conferences

Abstract:
Arrowhead Research Corporation (ARWR 1.16, -0.03, -2.52%) announced today that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at investor conferences.

Arrowhead to Present at Upcoming Investor Conferences

Pasadena, CA | Posted on April 20th, 2010

He will be presenting at the following investor conferences:

-- MDB Bright Lights Conference on May 11, 2010 at 1:30 pm PT in San Francisco, CA. Bright Lights will feature more than 40 of the "Best and Brightest" IP leaders identified by MDB's PatentVest IP intelligence platform as possessing technology leadership and potentially disruptive innovation.

-- Rodman & Renshaw's 6th Annual Global Healthcare Conference on May 17, 2010 at 11:55 am BST (6:55 am ET) in London, UK. An audio and slide webcast of the presentation will be available under the "Presentations and Events" page on the "Investor" section of Arrowhead's website at www.arrowres.com/conference.html. Following the live presentation, archives will be available for 90 days.

To request a one-on-one meeting with Dr. Anzalone at either conference, please contact Brandi Floberg at or call 212-481-2050.

####

About Arrowhead Research Corporation
Arrowhead Research Corporation is a nanotechnology company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies.

For more information, please click here

Contacts:
The Piacente Group
Brandi Floberg
212-481-2050

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: